Uronic Drugs Formulators Private Limited

Uronic Drugs Formulators Private Limited - business services in Lucknow, Uttar Pradesh, India. Directors, charges & compliance details.
CIN U47721UP2023PTC181766 Incorporated 09 May 2023 ROC Kanpur HQ Lucknow, Uttar Pradesh, India
Active Private Limited Company
Data last updated
Revenue · FY 2025
₹23.93 Lakh
▲ 90% YoY
Net profit · FY 2025
₹29,907
Net margin 1.2%
EBITDA · FY 2025
₹75,627
EBITDA margin 3.2%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
3 yrs
Est. 2023
Directors on board
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date

About Uronic Drugs Formulators Private Limited

Data last updated:

Uronic Drugs Formulators Private Limited is a private limited company based in Lucknow, Uttar Pradesh, India. It was incorporated on 09 May 2023.

The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U47721UP2023PTC181766.

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Akshay Saxena and Manisha Saxena.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Ed – 159 Sector Q, Lucknow, Uttar Pradesh, India – 226024.

As per the financials filed for FY 2025, the company reported a revenue of ₹23.93 Lakh, a growth of 90% compared to the previous year. For the same year it recorded a net profit of ₹29,907 (net margin 1.2%) and EBITDA of ₹75,627 (EBITDA margin 3.2%).

Company details

CIN U47721UP2023PTC181766
Registration Number 181766
Incorporation Date 09 May 2023
ROC Kanpur
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025

Contact details

Uronic Drugs Formulators Private Limited's registered office is in Lucknow, Uttar Pradesh.

  • Registered Address
    Ed – 159 Sector Q, Lucknow, Uttar Pradesh, India – 226024
Comprehensive company report
Uronic Drugs Formulators Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Uronic Drugs Formulators is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GWholesale and retail trade; repair of motor vehicles and motorcycles46Wholesale trade, except of motor vehicles and motorcycles

To see the full business activity and turnover split of Uronic Drugs Formulators Private Limited, buy the company report.

Financials of Uronic Drugs Formulators Private Limited

FY 2025 filings available

Uronic Drugs Formulators Private Limited reported revenue of ₹23.93 Lakh (up 90% YoY) for FY 2025.

Revenue · FY 2025
₹23.93 Lakh ▲ 90%
Net profit · FY 2025
₹29,907 margin 1.2%
EBITDA · FY 2025
₹75,627 margin 3.2%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 90%
EBITDA CAGR growth
1 year
▲ 27%

Revenue rose 90% in the latest year. EBITDA rose 27% in the latest year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹75,627
Profit Before Tax
Tax Expense
Net Profit (PAT)₹29,907
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24
Profitability
EBITDA Margin3.2%
Net Profit Margin1.2%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Uronic Drugs Formulators Private Limited, buy the company report.

Board of directors of Uronic Drugs Formulators Private Limited

Uronic Drugs Formulators has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Akshay SaxenaDirector09 May 20233 Years 5 MonthsCurrent
Manisha SaxenaDirector09 May 20233 Years 5 MonthsCurrent

Peer comparison

Uronic Drugs Formulators Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trade, except of motor vehicles and motorcycles), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Universal Panels (I) Private Limited₹23.96 Lakh (FY 2025)-83.0%Nagpur, Maharashtra, India
Divij Tukai Biofoods and Services Private Limited₹23.95 Lakh (FY 2025)-83.0%Kothale, Maharashtra, India
Sober Sales Private Limited₹23.94 Lakh (FY 2023)4.0%Delhi, India
Unnatinari Producer Company Limited₹23.94 Lakh (FY 2025)116.0%Dumka, Jharkhand, India
Combid Pharmaceuticals and Drugs Private Limited₹23.93 Lakh (FY 2025)12.0%Davanagere, Karnataka, India
Uronic Drugs Formulators Private Limitedthis company₹23.93 Lakh (FY 2025)₹29,9071.2%90.0%Lucknow, Uttar Pradesh, India
Crafter Pharmaceuticals Private Limited₹23.91 Lakh (FY 2025)462.0%Salem, Tamil Nadu, India
Heil Aarogyam Medicare Private Limited₹23.9 Lakh (FY 2025)116.0%Nagpur, Maharashtra, India
Shah Decoration Private Limited₹23.9 Lakh (FY 2025)370.0%Kolkata, West Bengal, India
Duravac Vacuum Technologies Private Limited₹23.9 Lakh (FY 2024)-5.0%Old Palam Road, Kakrola, Delhi, India
Kamala Kanta Paul Glass Private Limited₹23.89 Lakh (FY 2025)-62.0%Kolkata, West Bengal, India

To see the full peer comparison of Uronic Drugs Formulators Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Uronic Drugs Formulators Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Uronic Drugs Formulators Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Uronic Drugs Formulators Private Limited has 2 board changes on record since 2023: 2 appointments. The latest: Akshay Saxena was appointed as Director on 09 May 2023.

AGM
Uronic Drugs Formulators Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Uronic Drugs Formulators Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kanpur.
Appointed
Akshay Saxena was appointed as Director.
Appointed
Manisha Saxena was appointed as Director.
Incorporation
09 May 2023
Uronic Drugs Formulators Private Limited was registered on 09 May 2023 with Roc Kanpur & aged 3 years 5 months as per MCA records.

Frequently asked questions

Uronic Drugs Formulators is an active private limited company based in Lucknow, Uttar Pradesh, India. It was incorporated on 09 May 2023 (3+ years old) and is registered under CIN U47721UP2023PTC181766.

Uronic Drugs Formulators has 2 current directors:

The latest financial statements of Uronic Drugs Formulators on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2024 are in the company report.

The CIN (Corporate Identification Number) of Uronic Drugs Formulators is U47721UP2023PTC181766. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Uronic Drugs Formulators was incorporated on 09 May 2023, making it 3+ years old. It is registered with the Registrar of Companies, Kanpur.

The peers of Uronic Drugs Formulators by revenue are Universal Panels (I) Private Limited, Divij Tukai Biofoods and Services Private Limited, Sober Sales Private Limited, Unnatinari Producer Company Limited, Combid Pharmaceuticals and Drugs Private Limited and 5 more, all in the same principal business activity (wholesale trade, except of motor vehicles and motorcycles).

Akshay Saxena was appointed as Director on 09 May 2023. Manisha Saxena was appointed as Director on 09 May 2023.

The registered office of Uronic Drugs Formulators is at Ed – 159 Sector Q, Lucknow, Uttar Pradesh, India – 226024.

Uronic Drugs Formulators can be reached at its registered office: Ed – 159 Sector Q, Lucknow, Uttar Pradesh, India – 226024.

Uronic Drugs Formulators is registered under the jurisdiction of the Registrar of Companies (ROC), Kanpur.